Nasdaq(NDAQ)
Search documents
Beyond The Index: Why Nasdaq Is A Fintech Powerhouse
Seeking Alpha· 2024-12-26 19:05
The Nasdaq is one of the most profitable stock exchanges in the world. In the third quarter, they earned $1.1 billion in revenue, which was a 22% increase YoY. All while returning $138 million to shareholders through dividends and share buybacks.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving ...
2 Stocks to Buy Hand Over Fist Before the Nasdaq Soars Higher in 2025
The Motley Fool· 2024-12-26 10:30
Technology stocks have been in scintillating form on the market in the past couple of years, which is evident from the 86% gains clocked by the Nasdaq Composite index during this period, and the good news is that the impressive run in tech stocks could continue in 2025 as well.Historical trends show that the Nasdaq Composite has averaged gains of 17% in the year following a calendar year in which it logged 20%-plus gains. Meanwhile, the index has averaged an annual gain of 19% in a year following a year in ...
Nasdaq Bets on AI as Nvidia's 2025 Focus Shifts from Infrastructure to Innovation
FX Empire· 2024-12-26 10:23
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Is the Newest Member of the Nasdaq-100 -- a 764% Gainer Since Its IPO -- a Buy Going Into 2025?
The Motley Fool· 2024-12-25 14:30
Palantir was just added to the Nasdaq-100 and shares have been rocketing on the news.Outside of megacap technology companies, I'd argue that data analytics specialist Palantir Technologies (PLTR 2.09%) is the hottest name in the artificial intelligence (AI) realm. Palantir marked a lot of milestones this year -- most recently the company's entrance into the Nasdaq-100 index.While Palantir's early days as a public company were pretty rocky, the company has really come into its own over the last two years. Of ...
History Says the Nasdaq Will Soar in 2025. 1 Stock-Split Stock to Buy Before It Does.
The Motley Fool· 2024-12-25 09:05
This semiconductor and data center player has grown like wildfire over the past couple of years and shows no signs of slowing.The Nasdaq Composite has repeatedly reached new heights in 2024, notching more than 110 new all-time highs. Its record run has been fueled by a string of encouraging developments. The accelerating adoption of artificial intelligence (AI) was the initial catalyst for the rebound, but investor sentiment has been buoyed by waning inflation, recent interest rate cuts, and the U.S. electi ...
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 13, 2024
Newsfilter· 2024-12-24 19:40
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 13, 2024, short interest in 3,063 Nasdaq Global MarketSM securities totaled 11,912,589,852 shares compared with 11,857,580,215 shares in 3,065 Global Market issues reported for the prior settlement date of November 29, 2024. The mid-December short interest represents 2.65 days compared with 2.36 days for the prior reporting period. Short interest in 1,672 securities on The Nasdaq Capital MarketSM totaled 2,179,343,976 ...
S&P 500 and Nasdaq 100: Tesla and Nvidia Drive Gains as Year-End Rally Builds
FX Empire· 2024-12-24 15:49
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
History Says the Nasdaq Will Surge in 2025: 1 AI Stock to Buy Before It Does (Hint: It's Not Nvidia)
The Motley Fool· 2024-12-24 10:20
The market has gone into overdrive in 2024. Technology stocks especially so. After posting a 55% total return in 2023, the Nasdaq-100 index followed up with 27.5% total returns so far in 2024 (as of this writing). These are two of the strongest years in the index's history. Counterintuitively, momentum in the Nasdaq index typically begets more momentum. Historically, every time the Nasdaq produces 30% returns in a year, the following year sees gains of at least 19%, indicating that the momentum in technolog ...
Nasdaq Gains Around 1% As Tesla, Nvidia Rise Ahead Of Christmas: Greed Index Remains In 'Fear' Zone
Benzinga· 2024-12-24 09:35
The CNN Money Fear and Greed index showed a further easing in the fear level, while the index remained in the “Fear” zone on Monday.U.S. stocks settled higher on Monday, with the Nasdaq Composite surging around 1% to start the holiday-shortened week. Shares of Tesla Inc. TSLA gained more than 2%, while Nvidia Corp. NVDA added over 3% during the session.The New York Stock Exchange will close early Tuesday for Christmas Eve and remain closed Wednesday for Christmas Day.All three averages recorded losses last ...
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Newsfile· 2024-12-23 18:15
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesDecember 23, 2024 1:15 PM EST | Source: Phio Pharmaceuticals Corp.Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA gene silencing technology to make the body's immune cells more effective in killing cancer cells, today announced that it has entered ...